Biotech · Private company · Frederick, MD, US
Medigen, Inc.
Track this companyFree. Adds Medigen, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline1
- V4020Phase 1 · Venezuelan Equine EncephalitisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- A Phase 1 Study Evaluating the Safety, Tolerability, and Immunogenicity of V4020 Vaccine in Healthy VolunteersPHASE1 · NOT_YET_RECRUITING · started Aug 15, 2025ClinicalTrials.gov NCT07088822 · fetched Nov 12, 2026
NIH awards3
- DEVELOPMENT OF A LASSA FEVER VIRUS VACCINEFiscal year 2026 · $2.3MNIH RePORTER 75N93025C00034-P00002-9999-1 · fetched Nov 12, 2026
- DEVELOPMENT OF A LASSA FEVER VIRUS VACCINEFiscal year 2025 · $2.2MNIH RePORTER 75N93025C00034-0-9999-1 · fetched Nov 12, 2026
- Safety and Immunogenicity of novel, live-attenuated V4020 vaccine for Venezuelan Equine Encephalitis (VEE) in healthy adultsFiscal year 2024 · $562.6KNIH RePORTER 5U01AI155406-03 · fetched Nov 12, 2026